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Mre11/Rad50/Nbs1 complex (MRN) is essential to suppress the generation of double-strand breaks (DSBs) during DNA
replication. MRN also plays a role in the response to DSBs created by DNA damage. Hypomorphic mutations in Mre11
(which causes an ataxia-telangiectasia-like disease [ATLD]) and mutations in the ataxia-telangiectasia-mutated (ATM)
gene lead to defects in handling damaged DNA and to similar clinical and cellular phenotypes. Using Xenopus egg
extracts, we have designed a simple assay to define the biochemistry of Mre11. MRN is required for efficient activation
of the DNA damage response induced by DSBs. We isolated a high molecular weight DNA damage signaling complex
that includes MRN, damaged DNA molecules, and activated ATM. Complex formation is partially dependent upon Zn
2þ
and requires an intact Mre11 C-terminal domain that is deleted in some ATLD patients. The ATLD truncation can still
perform the role of Mre11 during replication. Our work demonstrates the role of Mre11 in assembling DNA damage
signaling centers that are reminiscent of irradiation-induced foci. It also provides a molecular explanation for the
similarities between ataxia-telangiectasia (A-T) and ATLD.
Introduction
Cellular response to DNA damage requires the coordinated
activation of cell cycle checkpoints with DNA repair (Zhou
and Elledge 2000). Failure to block S-phase entry in response
to damaged DNA or to repair the DNA leads to genomic
instability, the hallmark of cancer cells. DNA double-strand
breaks (DSBs) are particularly harmful to cells; if unrepaired,
DSBs generate aneuploidy and chromosomal translocations.
DSBs activate a network of signaling pathways that coor-
dinate the sensing and repair of the damage with cell cycle
arrest. The major signaling pathway triggered by DSBs
involves ataxia-telangiectasia-mutated (ATM) protein kinase
(Zhou and Elledge 2000). ATM is a serine-threonine kinase
related to the PI3 kinase family. DSBs activate ATM by
promoting its autophosphorylation (Bakkenist and Kastan
2003). Activated ATM phosphorylates protein substrates
involved in DNA repair, cell cycle arrest, and apoptosis.
Phosphorylation of Nbs1 by ATM is critical for S-phase
checkpoint (Gatei et al. 2000; Lim et al. 2000; Zhao et al.
2000). Nbs1 forms a trimeric complex with Mre11 and Rad50
(MRN) that is needed for DSB repair by homologous
recombination (Haber 1998; D’Amours and Jackson 2002;
Symington 2003). The three proteins are also essential for
vertebrate embryonic development and cell growth (Luo et al.
1999; Yamaguchi-Iwai et al. 1999; Zhu et al. 2001). MRN
prevents the accumulation of DSBs during DNA replication
(Costanzo et al. 2001).
ATM function is defective in patients carrying the recessive
genetic disorder ataxia-telangiectasia (A-T). A-T is charac-
terized by cerebellar degeneration, immunodeﬁciency, radi-
ation sensitivity, chromosomal instability, and cancer
predisposition (Gatti et al. 2001).
Hypomorphic mutations in Mre11 and Nbs1 give rise,
respectively, to an A-T-like disease (ATLD) and Nijmegen
breakage syndrome (NBS) (Digweed et al. 1999; Stewart et al.
1999; Tauchi et al. 2002). The clinical presentations of A-T
and ATLD are indistinguishable. NBS patients display the
symptoms of A-T and ATLD and, in addition, microcephaly
and mental deﬁciency (Tauchi et al. 2002). All three diseases
have similar cellular phenotypes. The mutant cells do not
respond appropriately to DSBs and display chromosome
abnormalities, hypersensitivity to ionizing radiations, radio-
resistant DNA synthesis, and an S-phase checkpoint defect
(Shiloh and Kastan 2001). These similarities strongly suggest
that ATM and MRN function in a common signaling pathway.
However, the molecular connection between these proteins is
yet to be determined.
Mre11 binds DNA and is both a 39-to-59 exonuclease and an
endonuclease that cleaves hairpin DNA structures (Paull and
Gellert 1999). Rad50 belongs to the structural maintenance of
chromosomes (SMC) family of proteins. Rad50 contains C-
terminal and N-terminal Walker A and B domains separated
by a long coiled-coil domain (de Jager et al. 2001; Hopfner et
al. 2002). Intramolecular assembly of the coiled-coil domain
brings the Walker A and B motifs together to generate a
functional nucleotide-binding module. A zinc-binding motif
(CXXC), or ‘‘zinc hook,’’ located at the base of the Rad50
coiled coil, mediates Rad50 dimerization through coordina-
tion of a zinc ion by four cysteine residues (Hopfner et al.
2002).
Rad50 dimer binds to two Mre11 molecules to form a stable
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PLoS BIOLOGYtetrameric complex with enhanced nuclease activities (Tru-
jillo and Sung 2001). hRad50/hMre11 complexes tether linear
duplex DNA molecules as demonstrated by scanning force
microscopy (de Jager et al. 2001). Based on these observations,
a model has been proposed in which the Mre11/Rad50
complex bridges broken DNA ends or sister chromatids
(van den Bosch 2003).
In yeast and mammalian cells, DSBs provoke the formation
of deﬁned nuclear structures called irradiation-induced foci
(IRIF). IRIF are believed to originate by chromatin modiﬁca-
tion, such as H2AX phosphorylation, at the site of the DSB,
followed by the recruitment of signaling and repair factors.
MRN localizes to DSBs, independently of H2AX phosphor-
ylation, and is critical for the formation of IRIF and the
consequent response to DNA damage (Petrini and Stracker
2003). Thus, cells with mutations in Mre11 or Nbs1 form IRIF
inefﬁciently. In ATLD cells, which carry a defective Mre11,
ATM activation is inhibited. Furthermore, ATM fails to
localize to sites of DSBs in cells lacking functional MRN (Uziel
et al. 2003). Taken together, these results suggest that MRN
plays an early and essential role in assembly of functional
signaling complexes at the sites of DNA damage. Further-
more, they place MRN upstream of ATM in the DNA damage
signaling pathway.
Cell-free extracts derived from Xenopus eggs recapitulate
signaling pathways triggered by DNA damage and have been
instrumental in unraveling the functions of ATM and Mre11
(Costanzo et al. 2000, 2001). Using this system, we show below
that fragmented DNA assembles with proteins into macro-
molecular structures enriched in activated ATM and MRN.
Their assembly requires MRN but not ATM. A truncated form
of Mre11 associated with ATLD does not support DNA–
protein complex assembly or DSB-induced activation of
ATM. This work provides a direct molecular connection
between ATM and MRN that can explain the similarities
between A-T and ATLD.
Results
A Rapid Assay for the Response to DNA DSBs
Addition of fragmented DNA to Xenopus egg extracts
triggers the ATM-signaling pathway (Costanzo et al. 2000).
We previously demonstrated this reaction by measuring an
ATM-dependent block to DNA replication in extracts treated
with DNA fragments (Costanzo et al. 2000). We now describe
a rapid assay to monitor the activation of DSB-responsive
protein kinases and to assess the contribution of ATM and
related protein kinases. Histone H2AX, a well-characterized
substrate for DSB-activated protein kinases, is phosphory-
lated in vivo at serine 139 by ATM and the ataxia-
telangiectasia-related protein (ATR) (Rogakou et al. 1998;
Burma et al. 2001; Costanzo et al. 2001; Ward and Chen 2001).
We used the C-terminal peptide of mouse H2AX (PAVGK-
KAS134QAS139QEY) as a reporter substrate to monitor the
response to DSBs. This peptide contains two putative SQ
phosphorylation sites for ATM or ATR: serines 134 and 139.
To test the speciﬁcity of the kinase(s) activated by DSBs, we
synthesized four peptides: wild-type and alanine substitutions
at serine 134 (S134A), serine 139 (S139A), and serines 134 and
139 (S134A/S139A).
Incubation of interphase extracts for 30 min with
fragmented DNA dramatically enhanced phosphorylation of
H2AX peptide (Figure 1A). Phosphorylated H2AX peptide
could be detected as early as 5 min after addition of
fragmented DNA (data not shown). S134A peptide was
phosphorylated to a level equivalent to wild-type peptide,
whereas S139A and S134/139A peptides were not modiﬁed.
Thus, phosphorylation of S139 in cell-free extracts in
response to DSBs mimics the in vivo situation (Rogakou et
al. 1998; Burma et al. 2001; Costanzo et al. 2001; Ward and
Chen 2001).
We next monitored phosphorylation of H2AX peptide in
extracts in which speciﬁc DNA damage response signaling
pathways were inhibited. X-ATM- and X-ATR-neutralizing
antibodies were used to abrogate ATM- and ATR-dependent
signaling, respectively. We previously demonstrated that these
antibodies completely inhibit ATM- and ATR-dependent
checkpoints in extracts (Costanzo et al. 2000, 2003). H2AX
peptide phosphorylation was signiﬁcantly reduced in extracts
treated with either X-ATM or X-ATR antibodies. Inhibition of
both ATR and ATM further decreased H2AX peptide
phosphorylation to 20% of control levels (Figure 1B, column
4). Inhibition of DNA-PK by depletion of Ku70 did not further
reduce H2AX peptide phosphorylation in the ATM/ATR-
inhibited extract. Finally, caffeine completely abrogated
H2AX peptide phosphorylation (Figure 1B, column 6). We
conclude that most H2AX phosphorylation induced by DSBs
in crude extracts is ATM- and ATR-dependent.
Functional MRN Is Required for ATM Activation
Experiments using cells carrying hypomorphic mutations
in Nbs1 or Mre11 (Carney et al. 1998; Varon et al. 1998;
Stewart et al. 1999; Petrini and Stracker 2003) suggested that
MRN also plays a role in sensing signals triggered by DSBs.
However, because Mre11 and Nbs1 are essential genes
(Yamaguchi-Iwai et al. 1999; Zhu et al. 2001; Tauchi et al.
2002), the effect of total Mre11 inactivation on the DNA
damage response could not be established. We asked whether
MRN was required in our system for DSB-dependent
activation of H2AX peptide phosphorylation. We have
previously established that Mre11 can be quantitatively
depleted from extracts (Costanzo et al. 2001). Figure 1C
shows that depletion of extracts for Mre11 abrogated the
response to DSB-containing DNA (Figure 1C, open squares).
Recombinant human MRN restored the DNA damage
response in the Mre11-depleted extract (Figure 1C, ﬁlled
squares).
ATLD, a syndrome characterized by failure of the DNA
damage response, is caused by hypomorphic mutations in
Mre11 (Stewart et al. 1999). In contrast to wild-type protein,
MRN containing a mutant Mre11 that lacks the C-terminal
DNA-binding domain (MRN-ATLD1/2) (Stewart et al. 1999;
Lee et al. 2003) did not restore activity to the Mre11-depleted
extract (Figure 1C, ﬁlled triangles).
At higher fragmented DNA concentrations (greater than or
equal to 100 ng/ll), H2AX peptide phosphorylation became
partly independent of ATM and Mre11. This phosphorylation
was sensitive to vanillin, a speciﬁc inhibitor of DNA-PK
(Durant and Karran 2003), and to Ku depletion (data not
shown).
In contrast to its inactivity in the DSB checkpoint reaction,
MRN-ATLD1/2 can fulﬁll the essential function of MRN in
preventing the accumulation of breaks during DNA repli-
cation. Figure 1D shows a TUNEL assay to detect DNA ends.
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Mre11 and DNA Damage Signaling ComplexesAs we previously reported (Costanzo et al. 2001), chromoso-
mal DNA replicated in Mre11-depleted extracts accumulated
DSBs. Addition of puriﬁed recombinant MRN to depleted
extracts largely prevented DNA fragmentation. MRN-ATLD1/
2 was as efﬁcient as wild-type MRN in supporting normal
DNA replication.
These results establish that MRN is required to activate the
DSB signal pathway and that the C-terminal region of Mre11
plays a critical role in this activation.
Linear DNA Fragments Trigger Mre11-Dependent Assem-
bly of Large DNA–Protein Complexes
Scanning force microscopy data (de Jager et al. 2001) show
that Mre11–Rad50 binds preferentially to broken DNA ends,
implying that direct interaction with linear DNA is essential
for MRN function. To investigate interactions between Mre11
and damaged DNA, interphase extract was incubated with
32P-labeled, 1 kb linear double-strand DNA molecules and
applied to a BioGel A15m column. This large-pore gel
ﬁltration resin includes most proteins and small DNA
fragments, but excludes protein–DNA complexes larger than
1.5310
7 kDa (Yuzakhov et al. 1999). When radio-labeled DNA
at the concentration of 50 ng/ll (equivalent to 4.5310
10 ends/
ll) was applied to the column in the absence of extract
(Figure 2A) or with extract but prior to incubation (data not
shown), all radioactivity was recovered in the included
volume. In contrast, when fragmented DNA was incubated
with extract prior to chromatography, radio-labeled DNA
resolved into two peaks (Figure 2B). Most DNA was still
recovered in the included volume (fractions 20–30). However,
a separate DNA peak corresponding to 3%–5% of the total
DNA loaded appeared in the excluded volume (fractions 9–
12). In contrast, labeled double-strand circular plasmid DNA
did not assemble into DNA–protein complexes after incuba-
tion; all labeled DNA was recovered in the included volume
(Figure 2C).
The peak in the excluded volume represents large DNA–
protein complexes that assembled in the extract, since it was
eliminated by treatment of the extract with proteinase K
immediately prior to chromatography (Figure 2D). Note that
the elution buffer contains detergent, ruling out possible
membrane aggregation.
To determine whether Mre11 plays a role in assembling the
DNA–protein complex, we incubated labeled DNA in an
Mre11-depleted extract (Figure 2E). In the absence of Mre11,
almost no radioactive label was recovered in the excluded
volume. Addition of recombinant human MRN to the
depleted extract restored the peak of high molecular weight
Figure 1. Functional MRN Is Required for the Response to DSBs, and
Mre11–ATLD Separates Essential and Nonessential Mre11 Functions
(A) The activity of protein kinases responsive to DSBs in Xenopus laevis
egg extracts was monitored by incorporation of
32P from c-
32P-ATP
into H2AX-derived peptides in the presence (plus DSB) or absence
(minus DSB) of fragmented DNA. Labels: Wild-Type, H2AX substrate
peptide containing serine 134 and serine 139; S134A, H2AX substrate
peptide with a substitution of serine 134 to alanine; S139A, H2AX
substrate peptide with a substitution of serine 139 to alanine; S134A/
S139A, H2AX substrate peptide with a substitution of both serines to
alanine.
(B) Extract incubated with linear DNA at 50 ng/ll (equivalent to 4.53
10
10 breaks/ll) was assayed with H2AX peptide in the presence of
buffer (Control), ATM-neutralizing antibodies (ATM Ab), ATR-
neutralizing antibodies (ATR Ab), ATM- and ATR-neutralizing
antibodies (ATM/ATR Abs), ATM- and ATR-neutralizing antibodies
in Ku70-depleted extracts (ATM/ATR Abs; Ku depletion), 5 mM
caffeine (Caffeine).
(C) DSB-responsive kinase activity was measured in the presence of 0,
5, 10, 25, and 50 ng/ll of linear DNA in control extract (ﬁlled
diamonds), mock-depleted extract (open diamonds), Mre11-depleted
extract (open squares), Mre11-depleted extract supplemented with
500 nM of recombinant MRN (ﬁlled squares), or Mre11-depleted
extract supplemented with 500 nM MRN-ATLD1/2 (ﬁlled triangles).
(D) DSB accumulation during DNA replication was monitored by
TUNEL assay. Postreplicative nuclei were isolated from a control
extract (stripes), Mre11-depleted extract (dots), Mre11-depleted
extract supplemented with MRN (diamonds), Mre11-depleted extract
supplemented with MRN-ATLD1/2 (gray) or mock-depleted extract
(white).
DOI: 10.1371/journal.pbio.0020110.g001
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Mre11 and DNA Damage Signaling ComplexesDNA–protein complex (Figure 2F, ﬁlled triangles). We
conclude, therefore, that the assembly of DNA–protein
complexes requires Mre11. Furthermore, addition of MRN
to nondepleted extract increased the amount of DNA in the
excluded volume (Figure 2F, ﬁlled squares), suggesting that
MRN is limiting in these extracts. MRN-ATLD1/2 did not
restore DNA–protein complex formation in an Mre11-
depleted extract (Figure 2F, open squares), indicating that
an intact Mre11 C-terminal domain is required for complex
assembly.
Rad50 protein forms intramolecular coiled-coil interac-
tions as well as intermolecular interactions via a Zn
2þ-
chelating hinge region coordinated by four cysteine residues,
the ‘‘zinc-hook’’ (Hopfner et al. 2002). Addition of TPEN, a
chelating agent speciﬁc for Zn
2þ (Shumaker et al. 1998),
partially inhibited formation of DNA–protein complexes
(Figure 2G, open circles). Finally, caffeine signiﬁcantly
reduced but did not eliminate the amount of labeled DNA
in the excluded peak (Figure 2G, open diamonds). This
suggests that assembly of the DNA–protein complex is
partially independent of ATM/ATR.
MRN Complex Is Part of the DNA–Protein Complexes That
Tethers Linear DNA Molecules
The previous experiments established that Mre11 is
required for assembly of DNA–protein complexes. To
demonstrate that Mre11 is an integral component of these
complexes, we immunoprecipitated Mre11 from chromato-
graphic fractions 10 and 25 and measured the
32P-DNA
content of the precipitate. We found labeled DNA associated
with MRN in fraction 10 (Figure 3A) but not in fraction 25,
although this fraction contains both Mre11 (see Figure 4A)
and
32P-DNA. As expected, immunoprecipitates of excluded
fractions following chromatography of Mre11-depleted ex-
tracts did not contain labeled DNA. When Mre11 immuno-
precipitated from control extracts was added to Mre11-
Figure 2. Requirements for the Assembly
of DNA–Protein Complexes
Elution proﬁles of a-
32P-dATP-labeled 1
kb linear DNA from BioGel A15m
chromatography columns. After loading,
fractions 1–31 were collected and radio-
activity was counted in a scintillation
counter.
(A–E) Complete elution proﬁle. (A)
Linear DNA alone. (B) Linear DNA
incubated 2 h in extract at 228C. (C)
a-
32P-dATP-labeled circular plasmid in-
cubated for 2 h in extract at 228C. (D)
Linear DNA incubated with extract
treated with 1 mg/ml proteinase K
immediately prior to loading. (E) Linear
DNA incubated in Mre11-depleted ex-
tract.
(F and G) Excluded volume (fractions 6–
14). (F) Linear DNA incubated in the
following extracts: Mre11-depleted ex-
tract (open triangles), Mre11-depleted
extract supplemented with 500 nM of
MRN (ﬁlled triangles), Mre11-depleted
extract supplemented with 500 nM of
MRN-ATLD1/2 (open squares), or con-
trol extract supplemented with MRN
(ﬁlled squares). (G) Linear DNA incu-
bated in the following extracts: control
extract (ﬁlled circles), extract treated
with 5 mM caffeine (open circles),
extract treated with TPEN at 100 lM
(open diamonds).
DOI: 10.1371/journal.pbio.0020110.g002
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Mre11 and DNA Damage Signaling Complexesdepleted extract, we again found MRN–DNA complexes in
fraction 10, but not in fraction 25 (Figure 3A).
We conclude that MRN is a component of the DNA–
protein complex.
To demonstrate that linear DNA molecules were linked in
the DNA–protein complex, we incubated extract with two
populations of fragmented DNA. DNA molecules of identical
sequence were either
32P-labeled or biotinylated. As ex-
pected, the radioactivity elution proﬁle was identical to that
observed with a single species of DNA molecules (data not
shown). Fraction 10 from the excluded volume and fraction
25 from the included volume were precipitated with PEG, and
biotinylated DNA molecules were afﬁnity-puriﬁed using
streptavidin-magnetic beads. The results of this assay show
clearly that
32P-DNA was associated with biotinylated DNA in
fraction 10, but not in fraction 25 (Figure 3B, columns 1 and
5). As expected, this association is Mre11-dependent. It was
abolished in Mre11-depleted extracts and restored in Mre11-
depleted extracts supplemented with recombinant MRN
(Figure 3B, columns 2 and 3).
Figure 3. Mre11 Tethers DSB-Containing DNA
(A) Control and treated extracts were incubated with a-
32P-dATP-
labeled DNA fragments and loaded onto BioGel A15 columns.
Fractions 10 and 25 were collected and incubated with polyclonal
antibodies against Mre11 or protein A beads alone. Beads were
collected and washed, and radioactivity was counted in a scintillation
counter. Shown are control extract (stripes), Mre11-depleted extract
(dots), or Mre11-depleted extract supplemented with Mre11 that had
been immunoprecipitated from the extract (diamonds), and extract
incubated with beads alone (black).
(B) Biotinylated DNA fragments were mixed with a-
32P-dATP-labeled
DNA fragments and incubated with various extracts. The extracts
were then loaded onto BioGel A15 columns. Fractions 10 and 25 were
collected and incubated with streptavidin-magnetic beads. Beads
were collected and washed, and radioactivity was counted in a
scintillation counter. Shown are control extract (stripes), Mre11-
depleted extract (dots), Mre11-depleted extract supplemented with
500 nM MRN (diamonds), and streptavidin beads (black).
DOI: 10.1371/journal.pbio.0020110.g003 Figure 4. DNA–Protein Complexes Are Signaling Centers Containing
Active Mre11 and ATM
(A) Western blot analysis of eluted fractions. Fraction numbers are
indicated at bottom. Fractions were collected following chromatog-
raphy of extracts incubated with fragmented (plus DSBs) or without
fragmented DNA (minus DSBs). Samples from fractions were
processed for SDS-PAGE and blotted with polyclonal antibodies
against Mre11, ATM, and phosphorylated ATM.
(B) Activity of ATM and ATR kinases in fractions 10 and 25. Extracts
were incubated with DNA fragments and applied to BioGel A15m
columns. Fraction 10 and fraction 25 from control extract were
assayed for H2AX activity in presence of buffer (light gray), ATM-
neutralizing antibodies (checks), ATR-neutralizing antibodies (dark
gray), 300 lM vanillin (stripes), or 5 mM caffeine (black).
(C) Activity of ATM and ATR kinases in fraction 10 and total extract.
Control extracts or extracts supplemented with 500 nM recombinant
MRN were incubated with DSBs and loaded onto BioGel A15m
columns. Total control extract and fraction 10 were assayed for
H2AX activity in the presence of buffer (light gray), ATM-neutraliz-
ing antibodies (checks), ATR-neutralizing antibodies (dark gray), or 5
mM caffeine (black).
DOI: 10.1371/journal.pbio.0020110.g004
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Mre11 and DNA Damage Signaling ComplexesMre11-Containing DNA–Protein Complexes Are Signaling
Centers
We next looked for a molecular connection between the
DNA–protein complex and protein kinase activation. We
monitored the distribution and modiﬁcation of Mre11 and
ATM in the chromatographic fractions described above.
Control extracts or extracts incubated with fragmented DNA
were chromatographed, and fractions 9–12 from the ex-
cluded volume and fractions 25–28 from the included volume
were PEG-precipitated and processed for Western blotting.
In untreated control extracts, Mre11 and ATM were
recovered only in the included volume. In extracts treated
with linear DNA, however, Mre11 and ATM were present in
both included and excluded fractions (Figure 4A, top four
panels). Relative to the total protein content of the fractions,
both Mre11 and ATM were enriched 18-fold and 46-fold
respectively in the excluded fraction, as determined by image
analysis. This conﬁrms that the high molecular weight
protein–DNA complexes contain Mre11, and additionally
establishes the presence of ATM in the complex. Strikingly,
Mre11 in the DNA–protein complex was in the active,
phosphorylated form (Costanzo et al. 2001). In contrast,
Mre11 in the included fractions was unmodiﬁed.
Furthermore, using an antibody that recognizes speciﬁcally
the active form of ATM (phosphorylated on the serine
equivalent to serine 1,981 of human ATM; Bakkenist and
Kastan 2003), we detected phosphorylated ATM only in the
excluded fractions (Figure 4A, third panel).
To conﬁrm that the excluded peak was enriched in active
ATM kinase, we compared H2AX peptide kinase activity in
fractions 10 and 25. We also determined the relative
contribution of ATM, ATR and DNA-PK to this activity
(Figure 4B). ATM and ATR protein kinase activities were
inhibited with the speciﬁc neutralizing antibodies described
above. DNA-PK activity was inhibited by vanillin, a speciﬁc
inhibitor of DNA-PK (Durant and Karran 2003). Most H2AX
kinase activity in fraction 10 was due to ATM, and to a lesser
extent, to ATR (Figure 4B). Vanillin had little effect on kinase
activity, indicating that the contribution of DNA-PK was
small in this fraction. In contrast, the kinase activity in
fraction 25 was sensitive to vanillin, but not to ATM- or ATR-
neutralizing antibodies (Figure 4B).
To provide further evidence that formation of MRN–DNA
complexes directly promotes ATM activation, we supple-
mented extracts with recombinant MRN and compared
H2AX peptide phosphorylation in total extract and in
fraction 10. The proportion of H2AX kinase that was
inhibited by ATM antibodies was signiﬁcantly higher in
fraction 10 than in total extract (compare columns 1 and 2
with columns 9 and 10 in Figure 4C). Incubation of extract
with recombinant MRN complex prior to chromatography
increased H2AX kinase activity in fraction 10 by 80%
(compare columns 1 and 5 in Figure 4C). The increased
kinase activity was entirely abrogated by anti-ATM antibody
(Figure 4C, columns 2 and 6).
Discussion
MRN Complex Is Required for ATM Activation
The three components of the MRN complex, Mre11, Rad50,
and Nbs1, are essential. Mouse embryos or chicken cells
carrying inactivating mutations in any of these proteins are
not viable (Luo et al. 1999; Yamaguchi-Iwai et al. 1999; Zhu et
al. 2001). This has made studies of MRN and its interacting
partners difﬁcult to approach. Although a connection
between ATM activation and MRN has long been known
(Petrini 2000), the precise mechanism that links these two
factors had not, to our knowledge, been elucidated. However,
using cell-free Xenopus egg extracts, it has been possible to
inactivate biochemically essential gene products. We previ-
ously determined that depletion of Mre11 and its associated
protein partners lead to DSB formation during DNA
replication (Costanzo et al. 2001). We used a similar strategy
to relate MRN inactivation and ATM function.
We provide several lines of evidence that indicate an MRN
requirement for ATM activation. The G1–S checkpoint
provoked by DSBs entails the sequential activation of protein
kinases, including ATM (Zhou and Elledge 2000). We show
that depletion of Mre11 from our extracts abolishes DSB-
dependent phosphorylation of H2AX peptide, a readout for
this cascade. ATM is the major contributor to H2AX
phosphorylation in these extracts. Our data strongly suggest
that MRN speciﬁcally activates ATM. Fragmented DNA
incubated in extracts forms high molecular weight DNA–
protein complexes that include MRN and ATM. Of H2AX
kinase activity in the complex in fraction 10, 75% is inhibited
by antibodies to ATM. Furthermore, addition of recombinant
MRN to extracts increases the yield of complex and
associated H2AX kinase activity. The enhanced activity is
entirely ATM-dependent.
ATR also contributes signiﬁcantly to H2AX phosphoryla-
tion in extracts treated with DSB-containing DNA. However,
ATM is activated earlier than ATR (data not shown). ATR
activation might be triggered by processing of DSBs into
single-strand DNA (ssDNA) (Zou and Elledge 2003). We
previously showed that ssDNA speciﬁcally stimulates ATR
(Costanzo et al. 2003). Since Mre11 depletion completely
prevents H2AX phosphorylation, we propose that Mre11
regulates both ATM-dependent early signaling from DSBs
and, possibly by its DNA exonucleolytic activity, delayed
signaling by ATR. Whereas caffeine completely inhibits
H2AX kinase, treatment with ATM/ATR antibodies combined
inhibits only 80% of H2AX kinase. This could be accounted
by an additional kinase such as ATX (Abraham 2001).
Alternatively, the neutralizing antibodies against ATM and
ATR might not inhibit 100% of the activity of respective
kinase towards H2AX.
MRN Tethers Linear DNA Molecules and Assembles DNA
Damage Signaling Complexes
We propose that MRN interacts with linear DNA to form
DNA–protein complexes that induce the phosphorylation
cascade responsible for the G1–S checkpoint. MRN assembles
with linear DNA molecules in vitro (de Jager et al. 2001). We
have isolated DNA–protein complexes from extracts incu-
bated with fragmented DNA as an excluded fraction from a
sizing column. The complexes require Mre11 for assembly,
contain linear DNA, and are highly enriched in Mre11 and
ATM. Immunoprecipitation studies with Mre11 antibodies
show the presence of tripartite complexes (Mre11–ATM–
fragmented DNA) in the excluded but not the void volume
(data not shown).
We believe that the formation of these complexes is a
critical step in the kinase cascade that leads to the G1–S
PLoS Biology | http://biology.plosjournals.org May 2004 | Volume 2 | Issue 5 | Page 0605
Mre11 and DNA Damage Signaling Complexescheckpoint. Several lines of evidence support this idea: (1)
Mre11-depleted extracts do not form complexes and fail to
activate ATM in response to DSBs. (2) Mre11 is concentrated
18-fold in the DNA–protein complexes and is heavily
phosphorylated. We previously established that phosphor-
ylation of Mre11 correlates with increased nuclease activity
(Costanzo et al. 2001). (3) ATM is enriched 46-fold in the
complexes and is phosphorylated on serine 1,981 (Bakkenist
and Kastan 2003). Therefore, activated ATM is only detected
in the DNA–protein complexes.
ATM, and possibly ATR, participates in the assembly of the
complexes. Pretreatment of extracts with caffeine, an
inhibitor of ATM and ATR, signiﬁcantly reduces the yield
of complex.
Some H2AX kinase activity is not associated with the DNA–
protein complex. This activity is principally accounted for by
DNA-PK.
Both MRN components Mre11 and Nbs1 are phosphory-
lated in response to DSBs. Nbs1 phosphorylation is ATM-
dependent (Gatei et al. 2000; Lim et al. 2000; Zhao et al. 2000).
Once recruited and activated within the signaling complex,
ATM might phosphorylate Nbs1 and Mre11, stabilizing the
complex and enhancing signaling activity. How might DNA–
MRN complexes initiate the cascade of events leading to ATM
activation? One of the critical steps could be to bring ATM in
close proximity with ‘‘chromatinized’’ DNA fragments. In-
deed, it was shown previously that ATM had afﬁnity for DSBs
(Andegeko et al. 2001; Uziel et al 2003). ATM enrichment at
sites of DSBs is consistent with the localized phosphorylation
of H2AX observed in vivo on chromatin ﬂanking DSBs (van
den Bosch et al. 2003).
Our previous work showed that at high doses of DNA
fragment (100 ng/ll, equivalent to 9 3 10
10 breaks/ll), the
ATM-dependent checkpoint does not require Mre11 function
(Costanzo et al. 2001). We also determined that H2AX
phosphorylation at 100 ng/ll of linear DNA is partially
Mre11-independent (data not shown). This could be due to
ATM activation by mass action at this dose of linear DNA as
well as to activation of DNA-PK (data not shown).
Molecular Bases for the Similarities between A-T and ATLD
A powerful argument for placing MRN and ATM in a
common signaling pathway derives from the similarities
between the clinical and the cellular phenotypes of A-T,
NBS, and ATLD (Digweed et al. 1999; Stewart et al. 1999;
Tauchi et al. 2002). Uziel et al. (2003) recently showed that the
ATM response to DSBs is impaired in ATLD cells, which carry
defective Mre11. After our work was completed, additional
studies reached similar conclusions using Mre11- or Nbs1-
deﬁcient cells (Carson et al. 2003; Mochan et al. 2003;
Theunissen et al. 2003). Our data provide a biochemical
framework to explain their observations.
The ATLD1/2 mutation, which generates a truncated
Mre11 that lacks part of its DNA-binding domain, is
compatible with viability. Thus, the mutation cannot abro-
gate the essential role of Mre11, although the mutant Mre11 is
defective in the damaged DNA response. We were able to
dissociate the two Mre11 reactions using simple biochemical
readouts. MRN-ATLD1/2 cannot activate ATM or form DNA–
protein complexes in response to DSBs. It can, however,
prevent accumulation of DSBs during chromosomal DNA
replication. We speculate that MRN-ATLD1/2 has reduced
afﬁnity for damaged DNA, resulting in labile interactions
with fragmented DNA and an inability to activate ATM.
What differentiates the essential function of Mre11 during
DNA replication from its ability to activate ATM? We suggest
that MRN association with chromatin during DNA replica-
tion and, possibly, during meiotic recombination differs from
its association with fragmented DNA. Consistent with this
hypothesis, chromatin association of Mre11 was shown, by
detergent extraction, to differ between replicative and c-
irradiated chromatin (Mirzoeva and Petrini 2003). We
previously demonstrated the association of Mre11 with
chromatin during normal DNA replication. One can envisage
MRN complexes forming on intact chromatin in a manner
similar to other SMC proteins such as cohesins, and involving,
perhaps, interactions with cohesins (Kim et al. 2002). These
complexes could perform the essential functions of MRN
during replication and recombination and would not require
an intact Mre11 C-terminal domain. This is consistent with
the viability and recombination proﬁciency of ATLD mutant
cells.
In contrast, tethering of damaged DNA containing DSBs
would require the Mre11 C-terminal DNA-binding domain.
Failure to interact with broken DNA would account for the
various phenotypes of A-T and ATLD.
Alternatively, C-terminal truncation of Mre11 might
weaken protein–protein interactions within the MRN com-
plex or between MRN and other proteins. This idea is
suggested by the Mre11 crystal structure, which shows that the
C-terminal domain in close proximity to a hydrophobic
region required for protein–protein interaction (Hopfner et
al. 2001). The truncated Mre11 might be unable to form the
protein–protein interactions required to stabilize MRN–DNA
complexes.
MRN–DNA Complexes and IRIF
The signaling complexes described above are reminiscent
of IRIF observed in mammalian cells (Maser et al. 1997).
Indeed, Mre11 is one of the ﬁrst proteins to localize to IRIF
following DNA damage (Petrini and Stracker 2003). Further-
more, cells from ATLD patients fail to establish foci (Stewart
et al. 1999), consistent with the inability of MRN-ATLD1/2 to
support the formation of DNA–protein complexes in
extracts. Recall that the ability to form foci and to activate
a DNA damage response in mammalian cells are closely
correlated (Stewart et al. 1999, 2003; Goldberg et al. 2003).
There are several similarities between the formation of
IRIF in vivo and assembly of the signaling structures in
extracts. Both require (1) intact Mre11 protein and, presum-
ably, binding of Mre11 to DNA, and (2) that IRIF form
independently of (Mirzoeva and Petrini 2001), but are
stabilized by, ATM, possibly by phosphorylation of Mre11
and/or Nbs1 (Gatei et al. 2000; Lim et al. 2000; Wu et al. 2000;
Zhao et al. 2000; Costanzo et al. 2001; Lukas et al. 2003).
As shown in Figure 5, our data suggest that MRN
concentrates and localizes DNA fragments and signaling
proteins such as ATM in IRIF-like structures. MRN may be
rate-limiting for assembly of these structures, even though
Mre11 can be recovered apart from DNA–protein complexes.
It was recently reported that the ends of broken chromo-
somes localize with phosphorylated H2AX to discrete spots in
the nucleus (Aten et al. 2004). The formation of these
structures requires functional MRN. We suggest that these
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tures that we observe in vitro. We have shown that DNA–
protein complexes are essential for the DNA damage
checkpoint. The challenge now is to dissect the assembly
pathway and to identify the rate-limiting steps in the
organization of these signaling centers.
Materials and Methods
Xenopus egg extracts. CSF-arrested extracts were freshly prepared
according to Costanzo et al. (2001). For kinase assays, extracts were
supplemented with 100 mg/ll cycloheximide and released into
interphase with 0.4 mM CaCl2.
DNA template. To prepare DNA fragments containing DSBs, we
used pBR322 plasmid digested with restriction endonucleases to yield
different types of ends (39-overhang, 59-overhang, and blunt). These
DNA fragments behaved equivalently in our assay (data not shown).
For the experiments shown in Figure 1, we used DNA digested with
HaeIII.
The 1 kb DNA fragment used for size fractionation experiments
was obtained by PCR on M13 ssDNA template using 22 nt primers
complementary to positions 5,570 and 6,584 (de Jager et al. 2001). The
32P-labeled fragment was obtained by addition of a-
32P-dATP (10
mCi/ll) to the PCR. The biotinylated 1 kb fragment was obtained by
PCR on M13 ssDNA template using a 22 nt primer complementary to
position 5,570 and a 22 nt primer complementary to position 6,584,
biotinylated on three thymidine residues (Sigma-Genosys, The
Woodlands, Texas, United States).
Kinase assays. Interphase egg extracts were incubated with DNA
fragments, DNA fragments and ATM-neutralizing Ab, ATR-neutral-
izing antibodies or 5 mM caffeine for 30 min at 228C. Extract (2 ll)
was mixed with 20 ll of EB kinase buffer (20 mM HEPES [pH 7.5], 50
mM NaCl, 10 mM MgCl2, 1 mM DTT, 1 mM NaF, 1 mM Na3VO4, and
10 mM MnCl2) supplemented with 0.5 mg/ml histone H2AX peptide
(Sigma-Genosys), 50 lM ATP, and 1 llo fc-
32P-ATP, 10 mCi/ll
(greater than 3,000 Ci/mmol). Samples were incubated at 308C for 20
min, and reactions were stopped by 20 ll of 50% acetic acid and
spotted on p81 phosphocellulose ﬁlter paper (Upstate Biotechnology,
Lake Placid, New York, United States). Filters were air-dried and
washed three times in 10% acetic acid. Radioactivity was quantiﬁed in
a scintillation counter.
For kinase assays of fractionated extracts, 50 ng/ll of 1 kb DNA
fragments was incubated in interphase extracts at 228C for 2 h.
Extracts were loaded onto the sizing column, and 250 ll fractions
were collected. Fractions were supplemented with 9% PEG-6000,
incubated on ice for 15 min, and spun in a microfuge at maximum
speed at 48C for 10 min. Pellets were resuspended in 20 llo fE B
buffer, and 2 ll was assayed with histone H2AX peptide substrate,
with or without ATM-neutralizing antibodies, ATR-neutralizing
antibodies, 300 lM vanillin, or 5 mM caffeine.
Egg extract fractionation. Interphase egg extracts (200 ll) were
incubated with or without 50 ng/llo f
32P-labeled 1 kb DNA fragments
for 2 h at 228C. They were then mixed with one volume of buffer A,
Figure 5. Schematic Representation of the
Mre11-Dependent Assembly of DNA Dam-
age Signaling Complexes
MRN promotes the assembly of DNA–
protein structures containing linear
DNA fragments enriched with active
ATM molecules. These active signaling
complexes resemble IRIF in that they are
the morphological and functional unit of
the DNA damage response.
DOI: 10.1371/journal.pbio.0020110.g005
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Mre11 and DNA Damage Signaling Complexesloaded onto a 15 3 300 mm column prepacked with BioGel A15m
resin (Bio-Rad, Hercules, California, United States) previously
equilibrated with buffer A at 48C. Extracts were mock-depleted,
Mre11-depleted, or Mre11-depleted supplemented with 500 nM MRN
or with 500 nM MRN-ATLD1/2. Control extracts were treated with
500 nM MRN and 100 lM TPEN or 5 mM caffeine or 1 mg/ml
proteinase K at 378C. After the samples were loaded, 15 ml of buffer
A (100 mM KCl, 40 mM HEPES [pH 8.0], 0.05% Tween-20, 10 mM
MgCl2, 1 mM ATP, 1 mM DTT, 1 mM NaF, 1 mM Na3VO4 leupeptin,
pepstatin, and aprotinin protease inhibitors) were gently applied to
the column. We collected 31 fractions of approximately 300 ll, and
radioactivity was measured in a scintillation counter. For the elution
proﬁle of the circular plasmid in control extracts, a 1.8 kb plasmid
derived form pUC19 with the SspI–SapI region deleted (Ristic et al.
2001) was used. Nicked plasmid was isolated and labeled by nick
translation in the presence of a-
32 P-dCTP, ligated, and incubated in
extracts. After the fractions were collected, radioactivity was counted
in a scintillation counter.
Precipitation of DNA fragments bound to Mre11. We incubated
200 ll of control, Mre11-depleted, or Mre11-depleted extract
supplemented with Mre11 precipitated from the extract with 50 ng/
llo f
32P-labeled 1 kb DNA fragments. Samples were applied to the
BioGel A15m sizing column and fractions were collected. Void
volume peak fraction 10 and included volume peak fraction 25 were
incubated with 50 ll of speciﬁc polyclonal antibodies against Mre11
prebound to protein A–Sepharose beads or beads alone overnight at
48C . Beads were washed with buffer A, and radioactivity was counted
in a scintillation counter.
Biotinylated DNA pulldown. We incubated 200 ll of control,
Mre11-depleted, or Mre11-depleted extract supplemented with 500
nM MRN with 50 ng/ll
32P-labeled 1 kb DNA fragments and 50 ng/ll
biotinylated 1 kb fragments for 2 h at 228C. Samples were applied to
the BioGel A15m sizing column, and fractions were collected. Void
volume peak fraction 10 and included volume peak fraction 25 were
incubated with kilobase-BINDER dynabeads (Dynal Biotech, Oslo,
Norway) or mock protein A dynabeads (Dynal Biotech), and DNA
fragments were isolated according to the kit protocol. Biotinylated
DNA fragments bound to beads were washed with buffer A, and
radioactivity was counted in a scintillation counter.
Recombinant Mre11/Rad50/Nbs1Proteins. Human MRN and MRN-
ATLD1/2 were puriﬁed from baculovirus-infected cells according to
published protocols (Paull and Gellert 1998). The recombinant
trimeric complex was used at a concentration of 500 nM, unless
otherwise speciﬁed.
X-Mre11 complex depletion/Ku depletion. For X-Mre11 complex
depletion, 50 ll of interphase extract was incubated with 25 llo f
protein A–Sepharose beads coupled with 50 ll of preimmune serum
or with 50 ll of X-Mre11 antiserum for 60 min at 48C. For Ku70/80
depletion, 50 ll of interphase extract was incubated with 25 llo f
protein A–Sepharose beads coupled to 50 ll of Ku antiserum
(Covance, Princeton, New Jersey, United States) for 60 min at 48C.
TUNEL assay. TUNEL assay was performed according to Costanzo
et al. (2001).
Western blot. We incubated 2 ll samples of interphase egg extracts
for 30 min at 228C with 50 ng/ll DNA fragments, DNA fragments and
5 mM caffeine, or with 50 ng/ll circular plasmid, and 2 ll samples
were recovered from the BioGel A15m column and precipitated with
9% PEG (see Figure 3A) were diluted in loading buffer, boiled for 3
min, electrophoresed on 6% or 10% SDS-PAGE, transferred to
nitrocellulose, and probed with polyclonal antibodies speciﬁc for
Xenopus ATM, Xenopus ATR, Xenopus Mre11, phosphoserine 1,981 of
human ATM (Rockland Immunochemicals, Gilbertsville, Pennsylva-
nia, United States), and phosphorylated ATM/ATR SQ substrates
(New England Biolabs, Beverly, Massachusetts, United States).
Acknowledgments
We would like to thank Dr. K. Cimprich for X-ATR antibodies, Dr. L.
Symington for reading the manuscript, and the members of the
Gautier lab for helpful suggestions. This work is supported by
American Cancer Society grant RSG CCG-103367, National Institutes
of Health grants (CA95866 and CA92245), and National Cancer
Institute contract N01-CN-25111 to JG.
Conﬂicts of interest. The authors have declared that no conﬂicts of
interest exist.
Author contributions. VC and JG conceived and designed the
experiments. VC performed the experiments. VC, MG, and JG
analyzed the data. TP contributed reagents/materials/analysis tools.
VC, MG, and JG wrote the paper. &
References
Abraham RT (2001) Cell cycle checkpoint signaling through the ATM and ATR
kinases. Genes Dev 15: 2177–2196.
Andegeko Y, Moyal L, Mittelman L, Tsarfaty I, Shiloh Y, et al. (2001) Nuclear
retention of ATM at sites of DNA double strand breaks. J Biol Chem 276:
38224–38230.
Aten JA, Stap J, Krawczyk PM, van Oven CH, Hoebe RA, et al. (2004) Dynamics
of DNA double-strand breaks revealed by clustering of damaged chromo-
some domains. Science 303: 92–95.
Bakkenist CJ, Kastan MB (2003) DNA damage activates ATM through
intermolecular autophosphorylation and dimer dissociation. Nature 421:
499–506.
Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ (2001) ATM
phosphorylates histone H2AX in response to DNA double-strand breaks. J
Biol Chem 276: 42462–42467.
Carney JP, Maser RS, Olivares H, Davis EM, Le Beau M, et al. (1998) The
hMre11/hRad50 protein complex and Nijmegen breakage syndrome: Link-
age of double-strand break repair to the cellular DNA damage response. Cell
93: 477–486.
Carson CT, Schwartz RA, Stracker TH, Lilley CE, Lee DV, et al. (2003) The
Mre11 complex is required for ATM activation and the G(2)/M checkpoint.
EMBO J 22: 6610–6620.
Costanzo V, Robertson K, Ying CY, Kim E, Avvedimento E, et al. (2000)
Reconstitution of an ATM-dependent checkpoint that inhibits chromoso-
mal DNA replication following DNA damage. Mol Cell 6: 649–659.
Costanzo V, Robertson K, Bibikova M, Kim E, Grieco D, et al. (2001) Mre11
protein complex prevents double-strand break accumulation during
chromosomal DNA replication. Mol Cell 8: 137–147.
Costanzo V, Shechter D, Lupardus PJ, Cimprich KA, Gottesman M, et al. (2003)
An ATR- and Cdc7-dependent DNA damage checkpoint that inhibits
initiation of DNA replication. Mol Cell 11: 203–213.
D’Amours D, Jackson SP (2002) The Mre11 complex: At the crossroads of DNA
repair and checkpoint signalling. Nat Rev Mol Cell Biol 3: 317–327.
de Jager M, van Noort J, van Gent DC, Dekker C, Kanaar R, et al. (2001) Human
Rad50/Mre11 is a ﬂexible complex that can tether DNA ends. Mol Cell 8:
1129–1135.
Digweed M, Reis A, Sperling K (1999) Nijmegen breakage syndrome:
Consequences of defective DNA double strand break repair. BioEssays 21:
649–656.
Durant, S, Karran P (2003) Vanillins—A novel family of DNA-PK inhibitors.
Nucleic Acids Res 31: 5501–5512.
Gatei M, Young D, Cerosaletti KM, Desai-Mehta A, Spring K, et al. (2000) ATM-
dependent phosphorylation of nibrin in response to radiation exposure.
Nat Genet 25: 115–119.
Gatti RA, Becker-Catania S, Chun HH, Sun X, Mitui M, et al. (2001) The
pathogenesis of ataxia-telangiectasia: Learning from a Rosetta stone. Clin
Rev Allergy Immunol 20: 87–108.
Goldberg M, Stucki M, Falck J, D’Amours D, Rahman D, et al. (2003) MDC1 is
required for the intra-S-phase DNA damage checkpoint. Nature 421: 952–
956.
Haber JE (1998) The many interfaces of Mre11. Cell 95: 583–586.
Hopfner KP, Karcher A, Craig L, Woo TT, Carney JP, Tainer JA (2001)
Structural biochemistry and interaction architecture of the DNA double
strand break repair Mre11 nuclease and Rad50-ATPase. Cell 105: 473–485.
Hopfner KP, Craig L, Moncalian G, Zinkel RA, Usui T, et al. (2002) The Rad50
zinc-hook is a structure joining Mre11 complexes in DNA recombination
and repair. Nature 418: 562–566.
Kim JS, Krasieva TB, LaMorte V, Taylor AM, Yokomori K (2002) Speciﬁc
recruitment of human cohesin to laser-induced DNA damage. J Biol Chem
277: 45149–45153.
Lee JH, Ghirlando R, Bhaskara V, Hoffmeyer MR, Gu J, et al. (2003) Regulation
of Mre11/Rad50 by Nbs1: Effects on nucleotide-dependent DNA binding and
association with ataxia-telangiectasia-like disorder mutant complexes. J Biol
Chem 278: 45171–45181.
Lim DS, Kim ST, Xu B, Maser RS, Lin J, et al. (2000) ATM phosphorylates p95/
nbs1 in an S-phase checkpoint pathway. Nature 404: 613–617.
Lukas C, Falck J, Bartkova J, Bartek J, Lukas J (2003) Distinct spatiotemporal
dynamics of mammalian checkpoint regulators induced by DNA damage.
Nat Cell Biol 5: 255–260.
Luo G, Yao MS, Bender CF, Mills M, Bladl AR, et al. (1999) Disruption of
mRad50 causes embryonic stem cell lethality, abnormal embryonic develop-
ment, and sensitivity to ionizing radiation. Proc Natl Acad Sci U S A 96:
7376–7381.
Maser RS, Monsen KJ, Nelms BE, Petrini JH (1997) hMre11 and hRad50 nuclear
foci are induced during the normal cellular response to DNA double-strand
breaks. Mol Cell Biol 17 6087–6096.
Mirzoeva OK, Petrini JH (2001) DNA damage-dependent nuclear dynamics of
the Mre11 complex. Mol Cell Biol 21: 281–288.
PLoS Biology | http://biology.plosjournals.org May 2004 | Volume 2 | Issue 5 | Page 0608
Mre11 and DNA Damage Signaling ComplexesMirzoeva OK, Petrini JH (2003) DNA replication-dependent nuclear dynamics
of the Mre11 complex. Mol Cancer Res 1: 207–218.
Mochan TA, Venere M, DiTullio RA Jr, Halazonetis TD (2003) 53BP1 and
NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating
ataxia-telangiectasia mutated (ATM) in response to DNA damage. Cancer
Res 63: 8586–8591.
Paull TT, Gellert M (1998) The 3C ¸t o 5 C ¸ exonuclease activity of Mre 11
facilitates repair of DNA double-strand breaks. Mol Cell 1: 969–979.
Paull TT, Gellert M (1999) Nbs1 potentiates ATP-driven DNA unwinding and
endonuclease cleavage by the Mre11/Rad50 complex. Genes Dev 13: 1276–
1288.
Petrini JH (2000) The Mre11 complex and ATM: Collaborating to navigate S
phase. Curr Opin Cell Biol 3: 293–296.
Petrini JH, Stracker TH (2003) The cellular response to DNA double-strand
breaks: Deﬁning the sensors and mediators. Trends Cell Biol 13: 458–462.
Ristic D, Wyman C, Paulusma C, Kanaar R (2001) The architecture of the
human Rad54-DNA complex provides evidence for protein translocation
along DNA. Proc Natl Acad Sci U S A 98: 8454–8460.
Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM (1998) DNA double-
stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol
Chem 273: 5858–5868.
Shiloh Y, Kastan MB (2001) ATM: Genome stability, neuronal development,
and cancer cross paths. Adv Cancer Res 83: 209–254.
Shumaker DK, Vann LR, Goldberg MW, Allen TD, Wilson KL (1998) TPEN, a
Zn
2þ/Fe
2þ chelator with low afﬁnity for Ca
2þ, inhibits lamin assembly,
destabilizes nuclear architecture and may independently protect nuclei
from apoptosis in vitro. Cell Calcium 23: 151–164.
Stewart GS, Maser RS, Stankovic T, Bressan DA, Kaplan MI, et al. (1999) The
DNA double-strand break repair gene hMRE11 is mutated in individuals
with an ataxia-telangiectasia-like disorder. Cell 99: 577–587.
Stewart GS, Wang B, Bignell CR, Taylor AM, Elledge SJ (2003) MDC1 is a
mediator of the mammalian DNA damage checkpoint. Nature 421: 961–966.
Symington LS (2002) Role of RAD52 epistasis group genes in homologous
recombination and double-strand break repair. Microbiol Mol Biol Rev 66:
630–670.
Tauchi H, Kobayashi J, Morishima K, van Gent DC, Shiraishi T, et al. (2002)
Nbs1 is essential for DNA repair by homologous recombination in higher
vertebrate cells. Nature 420: 93–98.
Theunissen JW, Kaplan MI, Hunt PA, Williams BR, Ferguson DO, et al. (2003)
Checkpoint failure and chromosomal instability without lymphomagenesis
in Mre11(ATLD1/ATLD1) mice. Mol Cell 12: 1511–1523.
Trujillo KM, Sung P (2001) DNA structure-speciﬁc nuclease activities in the
Saccharomyces cerevisiae Rad50*Mre11 complex. J Biol Chem 276: 35458–
35464.
Uziel T, Lerenthal Y, Moyal L, Andegeko Y, Mittelman L, et al. (2003)
Requirement of the MRN complex for ATM activation by DNA damage.
EMBO J 22: 5612–5621.
van den Bosch M, Bree RT, Lowndes NF (2003) The MRN complex:
Coordinating and mediating the response to broken chromosomes. EMBO
Rep 4: 844–849.
Varon R, Vissinga C, Platzer M, Cerosaletti KM, Chrzanowska KH, et al. (1998)
Nibrin, a novel DNA double-strand break repair protein, is mutated in
Nijmegen breakage syndrome. Cell 93: 467–476.
Ward IM, Chen J (2001) Histone H2AX is phosphorylated in an ATR-dependent
manner in response to replicational stress. J Biol Chem 276: 47759–47762.
Wu X, Ranganathan V, Weisman DS, Heine WF, Ciccone DN, et al. (2000) ATM
phosphorylation of Nijmegen breakage syndrome protein is required in a
DNA damage response. Nature 405: 477–482.
Yamaguchi-Iwai Y, Sonoda E, Sasaki MS, Morrison C, Haraguchi T, et al. (1999)
Mre11 is essential for the maintenance of chromosomal DNA in vertebrate
cells. EMBO J 18: 6619–6629.
Yuzhakov A, Kelman Z, O’Donnell M (1999) Trading places on DNA—A three-
point switch underlies primer handoff from primase to the replicative DNA
polymerase. Cell 96: 153–163.
Zhao S, Weng YC, Yuan SS, Lin YT, Hsu HC, et al. (2000) Functional link
between ataxia-telangiectasia and Nijmegen breakage syndrome gene
products. Nature 405: 473–477.
Zhou BB, Elledge SJ (2000) The DNA damage response: Putting checkpoints in
perspective. Nature 408: 433–439.
Zou L, Elledge SJ (2003) Sensing DNA damage through ATRIP recognition of
RPA-ssDNA complexes. Science 300: 1542–1548.
Zhu J, Petersen S, Tessarollo L, Nussenzweig A (2001) Targeted disruption of
the Nijmegen breakage syndrome gene NBS1 leads to early embryonic
lethality in mice. Curr Biol 11: 105–109.
PLoS Biology | http://biology.plosjournals.org May 2004 | Volume 2 | Issue 5 | Page 0609
Mre11 and DNA Damage Signaling ComplexesJune 2004  |  Volume 2  |  Issue 6  |  Page 0876 PLoS Biology  |  http://biology.plosjournals.org
Correction
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Mre11 Assembles Linear DNA Fragments into DNA Damage Signaling Complexes
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Because of a labeling error, the size of the DNA fragment used throughout the experiments was reported incorrectly 
(reported as 1 kb). The actual size of the DNA fragment was 131 bp. The fragment corresponds to the M13 DNA sequence 
from nucleotide 5656 to nucleotide 5787. This difference in fragment size does not affect any of the conclusions of the 
paper.
This correction note may be found online at DOI: 10.1371/journal.pbio.0020229.